Study of HS-20105 for advanced solid tumors
Part of Cancer clinical trials.
This trial is testing a new drug called HS-20105, given by injection, for people with advanced solid tumors that have stopped responding to standard treatments. The drug targets a protein on cancer cells to try to slow or stop their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of cancer that is advanced and has not responded to standard treatments or you cannot tolerate them.
- You have at least one tumor that can be measured on a scan (but not just in the brain or bones).
- You can provide a sample of your tumor from a biopsy (fresh or within the last 2 years).
- You are generally in good health (ECOG 0-1) and expected to live more than 12 weeks.
- You have not had certain prior treatments, including traditional Chinese medicine for cancer within 2 weeks or other anti-cancer therapies within 3-4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests HS-20089 in people with advanced solid cancers that have limited standard treatment options. It focuses on safety and early signs of whether the drug can shrink tumors or control them.
This phase 1 study tests an investigational drug called HS-20108 in people with advanced solid tumors. It aims to find a safe dose and see how well the drug works against cancer.
This Phase 1 trial tests HS-10386 (an experimental treatment) in people with advanced solid tumors that can’t be cured with standard options. The goal is to find a safe dose and see how the cancer responds.
This trial tests an investigational drug called HS-20093 for people with advanced esophageal cancer or other solid tumors that have not responded to prior treatment. The drug targets a protein on cancer cells called B7-H3, and the study aims to see if it can shrink tumors or slow their growth.
This study tests a new combination drug called HS-20093 for people with advanced solid tumors. It aims to see if it is safe and works against cancer that hasn't responded to other treatments.
This study tests a new drug called HC006 for advanced solid tumors that no longer respond to standard treatments. It aims to find a safe dose and see if it helps shrink tumors.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.